About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Cardiovascular Diseases’ and Type 2 Diabetes’ Biomarkers Identified

by Nancy Needhima on January 31, 2012 at 10:47 PM
Font : A-A+

Cardiovascular Diseases’ and Type 2 Diabetes’ Biomarkers Identified

Thirty one regions of the genome that were related with levels of circulating metabolites, i.e., small molecules that participate in diverse chemical reactions of the human body have been identified by researchers.

Many of the studied metabolites are biomarkers for cardiovascular disease or related disorders, thus the loci uncovered may provide valuable insight into the biological processes leading to common diseases.

Advertisement

Laboratory tests used in the clinic typically monitor one or few circulating metabolites.

The researchers at the Institute for Molecular Medicine Finland (FIMM) used a high throughput method called nuclear magnetic resonance (NMR) that can measure more than hundred different metabolites in one assay. This provides a much more in-depth picture of circulating metabolic compounds.
Advertisement

"Using this extensive analysis in thousands of people, we could identify a large number of genetic loci regulating the level of compounds circulating in the blood stream," said Dr. Samuli Ripatti, the leader of the study.

The team assayed 117 detailed metabolic markers, including lipoprotein subclasses, amino acids and lipids, and conducted the largest genome-wide association analysis of this type, in terms of study sample size of 8330 individuals from six Finnish population-based cohorts and 7.7 million genomic markers studied.

They revealed, in total, 31 genetic regions associated with the blood levels of the metabolites.

Eleven of the loci had not been previously shown to be associated with any metabolic measures.

Among the findings were two new loci affecting serum cholesterol subclass measures, well-established risk markers for cardiovascular disease, and five new loci affecting levels of amino acids recently discovered to be potential biomarkers for type 2 diabetes.

The discovered variants have significant effects on the metabolite levels, the effect sizes being in general considerably larger than the known common variants for complex disease have.

Also, using Finnish twin pair samples, the researchers indicated that the metabolite levels show a high degree of heritability.

"This result suggests that the studied metabolites are describing better the underlying biology than the routinely used laboratory tests. Therefore, the study provides further support for the use of detailed data on multitude of metabolites in genetic studies to provide novel biological insights and to help in elucidating the processes leading to common diseases," added Dr. Ripatti.

Source: ANI
Advertisement
Advertisement

Recommended Reading

open close
CONSULT ONLINE WITH A DOCTOR

×

Cardiovascular Diseases’ and Type 2 Diabetes’ Biomarkers Identified Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests